GATTA, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 36.029
AS - Asia 16.417
EU - Europa 9.542
AF - Africa 3.915
SA - Sud America 3.525
OC - Oceania 430
Continente sconosciuto - Info sul continente non disponibili 180
AN - Antartide 2
Totale 70.040
Nazione #
US - Stati Uniti d'America 34.036
SG - Singapore 6.518
CN - Cina 3.110
BR - Brasile 2.235
HK - Hong Kong 1.909
FI - Finlandia 1.142
VN - Vietnam 1.060
DE - Germania 1.057
IT - Italia 979
PL - Polonia 776
SE - Svezia 688
FR - Francia 518
UA - Ucraina 506
RU - Federazione Russa 395
GB - Regno Unito 369
AR - Argentina 255
IN - India 250
TR - Turchia 209
NL - Olanda 188
ID - Indonesia 183
MX - Messico 172
IE - Irlanda 170
IQ - Iraq 164
EC - Ecuador 163
ZA - Sudafrica 155
JP - Giappone 148
AT - Austria 145
CA - Canada 140
AO - Angola 137
ES - Italia 136
AL - Albania 129
PY - Paraguay 129
UZ - Uzbekistan 127
GR - Grecia 124
HN - Honduras 120
JO - Giordania 120
CO - Colombia 116
PA - Panama 116
CI - Costa d'Avorio 115
MA - Marocco 115
SA - Arabia Saudita 115
RO - Romania 114
KG - Kirghizistan 113
PE - Perù 113
AU - Australia 112
BJ - Benin 112
KE - Kenya 112
VE - Venezuela 112
AZ - Azerbaigian 111
BF - Burkina Faso 110
CL - Cile 110
LB - Libano 109
KZ - Kazakistan 107
AM - Armenia 106
CR - Costa Rica 106
JM - Giamaica 106
BY - Bielorussia 105
DK - Danimarca 105
GN - Guinea 105
LV - Lettonia 105
CM - Camerun 104
IR - Iran 104
MK - Macedonia 104
MW - Malawi 104
TW - Taiwan 104
UY - Uruguay 104
IS - Islanda 103
NO - Norvegia 103
PT - Portogallo 103
LC - Santa Lucia 102
MR - Mauritania 102
CY - Cipro 101
DZ - Algeria 101
ET - Etiopia 101
PH - Filippine 101
RS - Serbia 101
TJ - Tagikistan 101
CV - Capo Verde 100
EG - Egitto 100
SI - Slovenia 100
MN - Mongolia 99
SK - Slovacchia (Repubblica Slovacca) 99
TT - Trinidad e Tobago 99
ZM - Zambia 99
CG - Congo 98
MY - Malesia 98
GT - Guatemala 97
MU - Mauritius 97
SN - Senegal 97
EE - Estonia 96
GF - Guiana Francese 96
MG - Madagascar 96
PR - Porto Rico 96
TH - Thailandia 96
AE - Emirati Arabi Uniti 95
BA - Bosnia-Erzegovina 95
CW - ???statistics.table.value.countryCode.CW??? 94
DJ - Gibuti 94
GA - Gabon 94
KR - Corea 94
Totale 65.284
Città #
Fairfield 4.228
Singapore 3.342
Woodbridge 2.838
Chandler 2.578
Ashburn 2.569
Houston 2.447
Ann Arbor 2.328
Jacksonville 2.080
Hong Kong 1.835
Wilmington 1.817
Seattle 1.516
Cambridge 1.470
Boardman 935
Princeton 884
Santa Clara 815
Beijing 671
Bytom 641
Medford 492
Nanjing 447
San Diego 432
Helsinki 380
Des Moines 326
Roxbury 325
Dong Ket 298
Ho Chi Minh City 293
Los Angeles 253
Padova 184
Guangzhou 181
New York 176
Hanoi 173
São Paulo 165
Shenyang 155
Munich 151
Dublin 142
San Jose 138
Hebei 129
Nanchang 128
Changsha 120
Chicago 118
Norwalk 117
Amman 112
Abidjan 108
Luanda 108
Baku 106
Tashkent 103
Panama City 102
Conakry 100
Cotonou 100
Buffalo 96
Castries 96
Bishkek 95
Dakar 95
Jiaxing 95
Ulan Bator 95
Hefei 93
Libreville 93
Lusaka 93
Nairobi 92
Dushanbe 91
Nouakchott 91
Riga 90
Antananarivo 87
Yerevan 87
Bamako 85
Vienna 85
Bridgetown 83
Managua 83
Montevideo 82
Kigali 81
Noumea 81
Phnom Penh 80
Kampala 79
Nassau 78
Podgorica 78
Praia 78
Tokyo 78
Djibouti 77
Lilongwe 76
Ouagadougou 76
Reykjavik 75
Rio de Janeiro 75
Tianjin 75
San José 74
Willemstad 74
Accra 73
Harare 73
Kinshasa 73
Andorra la Vella 72
Cayenne 72
Tirana 72
Addis Ababa 71
Maputo 71
Tallinn 71
Lima 69
Minsk 69
Rome 68
Stockholm 68
Dar es Salaam 67
Havana 66
Brazzaville 65
Totale 43.318
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 286
Hypoalbuminemia 249
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 243
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 238
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 223
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 220
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 207
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study 205
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells 205
Positive cardiac inotropic effect of albumin infusion in rats with cirrhosis and ascites: Molecular mechanisms 205
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 205
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report 202
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 202
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 202
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 201
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 199
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. 198
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 198
Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing 198
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 197
Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study 196
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. 195
SERPINB3 induces epithelial-mesenchymal transition. 192
An Abnormal Gene Expression of the beta-Adrenergic System Contributes to the Pathogenesis of Cardiomyopathy in Cirrhotic Rats 191
Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. 187
Increased EETs participate in peripheral endothelial dysfunction of cirrhosis. 185
Alcohol- and substance-dependent subjects: The correlated factors in qualifying for liver transplantation 184
Nutrition and survival in patients with liver cirrhosis 183
Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. 183
Neurocognitive-neurological complications of liver transplantation: a review 182
SERPINB3, apoptosis and autoimmunity 182
Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus 180
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 180
Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. 180
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 179
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial 177
Role of HO/CO in the Control of Peripheral Circulation in Humans. 177
Thrombosis of the portal venous system 177
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae 176
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 174
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 174
A patients' and caregivers' perspective on hepatic encephalopathy. 174
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 174
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 173
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices 173
Comparison Between Nifedipine and Carvedilol in the Treatment of de novo Arterial Hypertension After Liver Transplantation: Preliminary Results of a Controlled Clinical Trial 172
Detection of minimal hepatic encephalopathy: Normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study 172
Neurological complications after orthotopic liver transplantation 172
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 172
Occult liver disease burden: Analysis from a large general practitioners’ database 172
Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy. 171
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 171
Hepatic progenitor cells express SerpinB3 170
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 169
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 169
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. 168
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 167
The liver: Another organ involved in Muir Torre syndrome? 167
Acute Kidney Injury Network (AKIN) criteria in the detection of renal failure in patients with cirrhosis, ascites and a serum creatinine < 1.5 mg/dl 165
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 165
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria 164
Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders 164
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout. 164
Kinetic of virological response during PEG-IFNs in chronic hepatitis C. 163
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 163
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost 162
Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damage 162
Detection of Minimal Hepatic Encephalopathy: EEG spectral analysis vs. cognitive evoked potentials 161
Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. 161
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase 161
Insight into the relationship between brain/behavioral speed and variability in patients with minimal hepatic encephalopathy 161
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 160
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 160
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study 159
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. 158
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis. 158
SQUAMOUS CELL CARCINOMA ANTIGEN VARIANTS OVEREXPRESSION IN HEPATOCELLULAR CARCINOMA. 157
Pathogenesis of cirrhotic cardiomyopathy: Impaired beta adrenergic gene expression profile in a rat model of CCL4-induced cirrhosis. 157
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 157
Visual attention in cirrhotic patients: a study on covert visual attention orienting. 156
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 156
Electroencephalographic analysis for the assessment of hepatic encephalopathy: Comparison of non-parametric and parametric spectral estimation techniques 156
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 155
Covert hepatic encephalopathy: Agreement and predictive validity of different indices 155
EVALUATION OF SPLANCHNIC ANGIOGRAPHY AS A PROGNOSTIC INDEX OF SURVIVAL IN PATIENTS WITH CIRRHOSIS 154
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 154
P300 latency for the diagnosis of Minimal Hepatic Encephalopathy: Evidence that spectral EEG analysis and psychometric tests are enough 154
Theophylline pharmacokinetics and liver function indexes in chronic liver disease. 153
Renal effects of nadolol in cirrhosis. 153
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS 152
Electroencephalography in patients with cirrhosis. 152
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 152
Paraumbilical vein patency in cirrhosis: effects on hepatic hemodynamics evaluated by Doppler sonography. 151
Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. 151
Prognostic benefit of the addition of an electroencephalographic (EEG) index to the MELD score: the MELD-EEG. 151
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG 151
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 151
Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children 150
First evidence that albumin can directly improve cardiac contractility in cirrhotic rats 150
Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats 149
Totale 17.611
Categoria #
all - tutte 213.180
article - articoli 154.723
book - libri 1.546
conference - conferenze 0
curatela - curatele 310
other - altro 1.547
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.759
Totale 379.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.859 0 0 0 0 0 0 136 465 701 424 566 567
2021/20226.125 104 1.023 664 457 228 285 211 621 305 78 610 1.539
2022/20235.477 1.205 539 151 556 918 859 7 336 612 36 196 62
2023/20242.167 102 372 234 178 122 199 92 75 80 49 323 341
2024/202511.858 27 895 571 534 1.711 272 410 822 1.094 422 2.087 3.013
2025/202622.552 1.112 4.080 5.911 5.876 3.728 1.664 181 0 0 0 0 0
Totale 70.141